Sotera Health将2025财年调整后的每股收益指导从0.75 - 0.82美元提高至0.81 - 0.86美元，而Est为0.79美元;确认2025财年销售指导为1.150亿美元-1.166亿美元，而Est为1.158亿美元

Sotera Health (NASDAQ: SHC) raises FY2025 Adj EPS guidance from $0.75-$0.82 to $0.81-$0.86 vs $0.79 analyst estimate. Affirms FY2025 sales outlook from $1.150 billion-$1.166 billion to $1.150 billion-$1.166 billion vs $1.158 billion estimate.